Trial Profile
Open Label Study to Evaluate Efficacy and Safety of Short-Term, Adjunctive Adrenocorticotropic Hormone (ACTH) Gel in Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 07 Sep 2022 Status changed from recruiting to completed.
- 04 Apr 2022 Planned End Date changed from 31 Dec 2021 to 30 Jun 2022.
- 04 Apr 2022 Planned primary completion date changed from 31 Dec 2021 to 30 Jun 2022.